Evidence map›Paper›PMID 38351271›Full record

ArticleUpdates in surgery2024

Impact of COVID-19 pandemic on thyroidectomy for malignant diseases in high-volume referral centers.

Marco Raffaelli, Luca Sessa, Carmela De Crea, Milena Pia Cerviere, Giuseppe Marincola, Francesca Zotta, Carlo Enrico Ambrosini, Benard Gjeloshi, Luigi De Napoli, Leonardo Rossi and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Updates in surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Marco RaffaelliDivision of Endocrine and Metabolic Surgery, Fondazione Policlinico Universitario "Agostino Gemelli" - IRCCS, 00168, Rome, Italy.
Luca SessaDivision of Endocrine and Obesity Surgery, Fondazione Istituto G. Giglio, Contrada Pietrapollastra-Pisciotto, 90015, Cefalù, PA, Italy. luca.sessa@policlinicogemelli.it.ORCID http://orcid.org/0000-0002-9894-4792
Carmela De CreaCentro di Ricerca in Chirurgia delle Ghiandole Endocrine e dell'Obesità, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
Milena Pia CerviereDivision of Endocrine Surgery, Fatebenefratelli Isola Tiberina - Gemelli Isola, 00186, Rome, Italy.
Giuseppe MarincolaDivision of Endocrine and Metabolic Surgery, Fondazione Policlinico Universitario "Agostino Gemelli" - IRCCS, 00168, Rome, Italy.
Francesca ZottaDivision of Endocrine and Metabolic Surgery, Fondazione Policlinico Universitario "Agostino Gemelli" - IRCCS, 00168, Rome, Italy.
Carlo Enrico AmbrosiniDepartment of Surgical, Medical, Molecular Pathology and Critical Area, Endocrine Surgery Unit, Pisa University Hospital, 56124, Pisa, Italy.
Benard GjeloshiDepartment of Surgical, Medical, Molecular Pathology and Critical Area, Endocrine Surgery Unit, Pisa University Hospital, 56124, Pisa, Italy.
Luigi De NapoliDepartment of Surgical, Medical, Molecular Pathology and Critical Area, Endocrine Surgery Unit, Pisa University Hospital, 56124, Pisa, Italy.
Leonardo RossiDepartment of Surgical, Medical, Molecular Pathology and Critical Area, Endocrine Surgery Unit, Pisa University Hospital, 56124, Pisa, Italy.
Rossella EliseiDepartment of Clinical and Experimental Medicine, Endocrine Unit, Pisa University Hospital, 56124, Pisa, Italy.
Alfredo PontecorviCentro di Ricerca in Chirurgia delle Ghiandole Endocrine e dell'Obesità, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
Fulvio BasoloDepartment of Surgical, Medical, Molecular Pathology and Critical Area, Pathology Unit, Pisa University Hospital, 56124, Pisa, Italy.
Esther Diana RossiDivision of Anatomic Pathology and Histology, Fondazione Policlinico Universitario "Agostino Gemelli"-IRCCS, 00168, Rome, Italy.
Rocco BellantoneDivision of Endocrine and Metabolic Surgery, Fondazione Policlinico Universitario "Agostino Gemelli" - IRCCS, 00168, Rome, Italy.
Gabriele MaterazziDepartment of Surgical, Medical, Molecular Pathology and Critical Area, Endocrine Surgery Unit, Pisa University Hospital, 56124, Pisa, Italy.
Azienda Ospedaliera Universitaria Pisana · ITUniversità Cattolica del Sacro Cuore · ITAgostino Gemelli University Polyclinic · ITFatebenefratelli Hospital · ITFondazione Istituto G. Giglio di Cefalù · ITUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe COVID-19 pandemic has limited the availability of healthcare resources for non-COVID patients and decreased elective surgeries, including thyroidectomy. Despite the prioritization of surgical procedures, it has been reported that thyroidectomy for thyroid cancer (TCa) was adversely impacted. We assessed the impact of the pandemic on the surgical activities of two high-volume referral centers. MATERIALS AND

methodsPatients operated at two National Referral Centers for Thyroid Surgery between 03/01/2020 and 02/28/2021 (COVID-19 period) were included (P-Group). The cohort was compared with patients operated at the same Centers between 03/01/2019 and 02/29/2020 (pre-COVID-19 pandemic) (C-Group).

resultsOverall, 7017 patients were included: 2782 in the P-Group and 4235 in the C-Group. The absolute number of patients with TCa was not significantly different between the two groups, while the rate of malignant disease was significantly higher in the P-Group (1103/2782 vs 1190/4235) (P < 0.0001). Significantly more patients in the P-Group had central (237/1103 vs 232/1190) and lateral (167/1103 vs 140/1190) neck node metastases (P = 0.001). Overall, the complications rate was significantly lower (11.9% vs 15.1%) and hospital stay was significantly shorter (1.7 ± 1.5 vs 1.9 ± 2.2 days) in the P-Group (P < 0.05).

conclusionThe COVID-19 pandemic significantly decreased the overall number of thyroidectomies but did not affect the number of operations for TCa. Optimization of management protocols, due to limited resource availability for non-COVID patients, positively impacted the complication rate and hospital stay.

Indexed as

COVID-19ThyroidectomyThyroid NeoplasmsAdultAgedElective Surgical ProceduresFemaleHospitals, High-VolumeHumansLength of StayMaleMiddle AgedPandemicsReferral and ConsultationRetrospective StudiesComplicationsCOVID-19 pandemicThyroid carcinomaThyroidectomyThyroid surgeryVolume outcome

Identifiers

PMID38351271
OpenAlexW4391772558

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.